New vitamin compound shows promise for reversing Alzheimer's damage to the brain

An enhanced version of vitamin K could help reverse brain damage from Alzheimer’s disease, a study has found.

Alzheimer’s and many other neurodegenerative diseases are marked by a loss of brain neurons. While most medications treat only the symptoms, researchers from the Department of Bioscience and Engineering at Shibaura Institute of Technology in Japan set out to determine whether a new approach could replace the lost cells.

Vitamin K is an essential nutrient that aids with blood clotting, bone health and other important functions in the body, according to the National Institutes of Health. 

SIMPLE DIET CHANGE MAY SUPPORT GUT HEALING FOR CANCER SURVIVORS, RESEARCHERS SAY

While it has been shown to support brain protection and neuron creation, the natural forms of vitamin K — including menaquinone-4 (MK-4) — might not be powerful enough to effectively treat neurodegenerative diseases, experts say.

To boost its potency, researchers from the Department of Bioscience and Engineering at Shibaura Institute of Technology in Japan developed new, stronger forms of the vitamin.

They did this by creating 12 new versions of vitamin K and combining it with retinoic acid, an active metabolite of vitamin A that helps brain cells grow and develop.

CLICK HERE TO GET THE FOX NEWS APP

In lab tests, the new lab-made versions of vitamin K were about three times more effective than natural vitamin K at helping immature brain cells develop into neurons, according to study co-lead Associate Professor Yoshihisa Hirota.

The new vitamin K compound was also shown to successfully cross the blood-brain barrier in animal tests. 

Another important benefit, the researchers noted, is that the new molecules retained the same benefits of vitamin K and vitamin A while showing stronger brain-cell activity.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The findings were published in the journal ACS Chemical Neuroscience.

“Since neuronal loss is a hallmark of neurodegenerative diseases such as Alzheimer’s disease, these analogues may serve as regenerative agents that help replenish lost neurons and restore brain function,” Hirota said in a press release.

Looking ahead, the research team plans to test the new compounds in animal and human studies, in hopes that this could lead to a new approach for slowing or repairing brain degeneration for patients with neurodegenerative diseases. 

“A vitamin K-derived drug that slows the progression of Alzheimer’s disease or improves its symptoms could not only improve the quality of life for patients and their families, but also significantly reduce the growing societal burden of healthcare expenditures and long-term caregiving,” Hirota added.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Heather M. Snyder, Ph.D., senior vice president of medical and scientific relations of the Alzheimer’s Association in Chicago, was not involved in the study but commented on the “interesting though preliminary” findings.

“This is further evidence of the wide variety of potential treatment avenues being pursued in research about Alzheimer’s and other diseases that cause dementia today,” she told Fox News Digital.

“These are complex diseases; effective treatment likely will require combining multiple approaches,” she went on. “Moving forward, it is important to leverage all evidence-based tools, including advancing discoveries from test tubes and computer simulations to more sophisticated models and — if warranted by positive results — testing in people.”

CLICK HERE FOR MORE HEALTH STORIES

“Only then can we confidently tell whether it has the potential for treating Alzheimer’s and other diseases that cause dementia.”

People should speak with a doctor before beginning any supplement regimen, doctors advise.